These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10678495)

  • 81. Arterial baroreflex dysfunction fails to mimic Parkinson's disease in rats.
    Yu JG; Wu J; Shen FM; Cai GJ; Liu JG; Su DF
    J Pharmacol Sci; 2008 Sep; 108(1):56-62. PubMed ID: 18776711
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Neuroprotective effect of chronic inactivation of the subthalamic nucleus in a rat model of Parkinson's disease.
    Piallat B; Benazzouz A; Benabid AL
    J Neural Transm Suppl; 1999; 55():71-7. PubMed ID: 10335494
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Modeling fall propensity in Parkinson's disease: deficits in the attentional control of complex movements in rats with cortical-cholinergic and striatal-dopaminergic deafferentation.
    Kucinski A; Paolone G; Bradshaw M; Albin RL; Sarter M
    J Neurosci; 2013 Oct; 33(42):16522-39. PubMed ID: 24133257
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Differentiation of motor inactivation from movement asymmetry effects in an animal model of hemi-parkinsonism.
    Fornaguera J; Carey RJ; Dai H; Huston JP; Schwarting RK
    Neuroreport; 1994 Dec; 6(1):173-6. PubMed ID: 7703408
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Both pre- and post-lesion experiential therapy is beneficial in 6-hydroxydopamine dopamine-depleted female rats.
    Jadavji NM; Metz GA
    Neuroscience; 2009 Jan; 158(2):373-86. PubMed ID: 19032978
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion.
    Matsuura K; Kabuto H; Makino H; Ogawa N
    J Neurosci Methods; 1997 Apr; 73(1):45-8. PubMed ID: 9130677
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Asymmetrical influence of mesocortical dopamine depletion on stress ulcer development and subcortical dopamine systems in rats: implications for psychopathology.
    Sullivan RM; Szechtman H
    Neuroscience; 1995 Apr; 65(3):757-66. PubMed ID: 7609874
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Experimental parkinsonism modulates multiple genes involved in the transduction of dopaminergic signals in the striatum.
    Napolitano M; Centonze D; Calce A; Picconi B; Spiezia S; Gulino A; Bernardi G; Calabresi P
    Neurobiol Dis; 2002 Aug; 10(3):387-95. PubMed ID: 12270699
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Tongue force and timing deficits in a rat model of Parkinson disease.
    Ciucci MR; Russell JA; Schaser AJ; Doll EJ; Vinney LM; Connor NP
    Behav Brain Res; 2011 Sep; 222(2):315-20. PubMed ID: 21459116
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Estimation of the convulsive effect of cyanide in rats.
    Cassel GE
    Pharmacol Toxicol; 1995 Oct; 77(4):259-63. PubMed ID: 8577637
    [TBL] [Abstract][Full Text] [Related]  

  • 91. MRI, brain iron and experimental Parkinson's disease.
    Hall S; Rutledge JN; Schallert T
    J Neurol Sci; 1992 Dec; 113(2):198-208. PubMed ID: 1487755
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Akinesia and postural abnormality after unilateral dopamine depletion.
    Johnson RE; Schallert T; Becker JB
    Behav Brain Res; 1999 Oct; 104(1-2):189-96. PubMed ID: 11125738
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Retraction: Establishment of a Parkinson's disease model in rats via striatal one-site double injection: Feasibility observation.
    Neural Regen Res; 2020 Dec; 15(12):2317. PubMed ID: 32594055
    [No Abstract]   [Full Text] [Related]  

  • 94. A mind in motion: Exercise improves cognitive flexibility, impulsivity and alters dopamine receptor gene expression in a Parkinsonian rat model.
    Zhuo W; Lundquist AJ; Donahue EK; Guo Y; Phillips D; Petzinger GM; Jakowec MW; Holschneider DP
    Curr Res Neurobiol; 2022; 3():100039. PubMed ID: 36518341
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Sleep and circadian rhythms in Parkinson's disease and preclinical models.
    Hunt J; Coulson EJ; Rajnarayanan R; Oster H; Videnovic A; Rawashdeh O
    Mol Neurodegener; 2022 Jan; 17(1):2. PubMed ID: 35000606
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Upregulation of Cysteine Protease Cathepsin X in the 6-Hydroxydopamine Model of Parkinson's Disease.
    Pišlar A; Tratnjek L; Glavan G; Živin M; Kos J
    Front Mol Neurosci; 2018; 11():412. PubMed ID: 30450037
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Dopaminergic degeneration is enhanced by chronic brain hypoperfusion and inhibited by angiotensin receptor blockage.
    Rodriguez-Perez AI; Dominguez-Meijide A; Lanciego JL; Guerra MJ; Labandeira-Garcia JL
    Age (Dordr); 2013 Oct; 35(5):1675-90. PubMed ID: 22986582
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Circadian and sleep disorders in Parkinson's disease.
    Videnovic A; Golombek D
    Exp Neurol; 2013 May; 243():45-56. PubMed ID: 22935723
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Subtle cardiovascular dysfunction in the unilateral 6-hydroxydopamine-lesioned rat.
    Slack K; Billing R; Matthews S; Allbutt HN; Einstein R; Henderson JM
    Parkinsons Dis; 2010 Mar; 2010():427810. PubMed ID: 20976085
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Time-dependent striatal dopamine depletion after injection of 6-hydroxydopamine in the rat. Comparison of single bilateral and double bilateral lesions.
    Ben V; Blin O; Bruguerolle B
    J Pharm Pharmacol; 1999 Dec; 51(12):1405-8. PubMed ID: 10678495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.